Literature DB >> 25083488

Histologic evaluation of sentinel and non-sentinel axillary lymph nodes in breast cancer by multilevel sectioning and predictors of non-sentinel metastasis.

Piyarat Jeeravongpanich1, Tuenjai Chuangsuwanich1, Chulaluk Komoltri1, Adune Ratanawichitrasin1.   

Abstract

Sentinel lymph node (SLN) provides accurate nodal staging for breast cancer. This technique has been introduced in Siriraj Hospital since 1998. The goal of this study is to assess its accuracy in predicting the state of the axilla, and compare the results of standard examination and multilevel sectioning. A retrospective analysis of 195 breast cancer patients who underwent both SLN biopsy (using dye alone as the lymphatic mapping) and axillary node dissection during 1998-2002 were analyzed. All slides including SLNs and the non-SLNs (NSLNs) were reviewed and multilevel study was performed on all SLNs and NSLNs [four levels of hematoxylin-eosin (HE) at 200 µm interval and keratin stains on the first and fourth levels]. Of 195 patients, 30% of cases were SLN-positive (32 NSLN-positive and 27 NSLN-negative). Additional study could detect positive axillary nodes 10.8% (4 SLN-positive and 5 NSLN-positive) more than standard HE stain. The false negative rate increased from 20.3% to 24.1%. The concordance between SLN and NSLN statuses was 89.7%. The sensitivity was 75.9%. By multivariate analysis, the significant predictors for axillary node metastasis were tumor size of more than 2.2 cm, histologic type of invasive ductal carcinoma (IDC), not otherwise specified (NOS) and lymphovascular invasion (LVI). By univariable analysis, the significant predictors of NSLN metastasis after positive-SLN were outer location of the tumor, LVI and perinodal extension. In conclusion, use of multilevel and immunohistochemistry increased detection of positive-SLNs. Caution should be kept in accepting SLN biopsy using peritumoral dye technique alone as the procedure for staging due to a high false-negative rate. The concordance rate of 89.7% confirmed the reliability of SLN. Outer location of tumor, LVI and perinodal extension is significant predictors of positive-NSLN after positive-SLN.

Entities:  

Keywords:  Breast cancer; immunohistochemistry study; mutilevel study; non-sentinel lymph node (NSLN); sentinel lymph node (SLN)

Year:  2014        PMID: 25083488      PMCID: PMC4115770          DOI: 10.3978/j.issn.2227-684X.2014.02.01

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  25 in total

Review 1.  Sentinel lymph node biopsy in breast cancer.

Authors:  J Bonnema; C J H van de Velde
Journal:  Ann Oncol       Date:  2002-10       Impact factor: 32.976

2.  Comparison of blue dye and isotope with blue dye alone in breast sentinel node biopsy.

Authors:  David B Y Syme; John P Collins; G Bruce Mann
Journal:  ANZ J Surg       Date:  2005-09       Impact factor: 1.872

Review 3.  Histopathologic examination of the sentinel lymph nodes.

Authors:  Gábor Cserni
Journal:  Breast J       Date:  2006 Sep-Oct       Impact factor: 2.431

4.  Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer.

Authors:  S F Abdessalam; E E Zervos; M Prasad; W B Farrar; L D Yee; M J Walker; W B Carson; W E Burak
Journal:  Am J Surg       Date:  2001-10       Impact factor: 2.565

5.  Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer?

Authors:  C Reynolds; R Mick; J H Donohue; C S Grant; D R Farley; L S Callans; S G Orel; G L Keeney; T J Lawton; B J Czerniecki
Journal:  J Clin Oncol       Date:  1999-06       Impact factor: 44.544

6.  Recommendations for sentinel lymph node processing in breast cancer.

Authors:  M A Yared; L P Middleton; T L Smith; H W Kim; M I Ross; K K Hunt; A A Sahin
Journal:  Am J Surg Pathol       Date:  2002-03       Impact factor: 6.394

Review 7.  Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual.

Authors:  S Eva Singletary; James L Connolly
Journal:  CA Cancer J Clin       Date:  2006 Jan-Feb       Impact factor: 508.702

8.  Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.

Authors:  Kathie-Ann Joseph; Mahmoud El-Tamer; Ian Komenaka; Andrea Troxel; Beth Ann Ditkoff; Freya Schnabel
Journal:  Arch Surg       Date:  2004-06

Review 9.  Pathologic examination of sentinel lymph nodes from melanoma patients.

Authors:  Richard A Scolyer; Rajmohan Murali; Stanley W McCarthy; John F Thompson
Journal:  Semin Diagn Pathol       Date:  2008-05       Impact factor: 3.464

10.  Sentinel lymph node biopsy versus axillary clearance in operable breast cancer: The RACS SNAC trial, a multicenter randomized trial of the Royal Australian College of Surgeons (RACS) Section of Breast Surgery, in collaboration with the National Health and Medical Research Council Clinical Trials Center.

Authors:  P Grantley Gill
Journal:  Ann Surg Oncol       Date:  2004-03       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.